Eduardo Dunayevich
- Pharmacology top 0.2%
- Pharmacology and Obesity Treatment 9
- Cannabis and Cannabinoid Research 9
- Treatment of Major Depression 6
- Psychiatry and Mental health top 1%
- Schizophrenia research and treatment 15
- Epilepsy research and treatment 9
- Bipolar Disorder and Treatment 6
- Biological Psychiatry top 5%
-
- Eating Disorders and Behaviors 7
-
- Health Systems, Economic Evaluations, Quality of Life 6
- Co-authors
- J. EricksonFrank L. GreenwayKen FujiokaDennis Dong Hwan KimMaria GuttadauriaPaul E. KeckRaymond A PlodkowskiSunder Mudaliar
- Journals
- The Lancet (1 paper)Journal of the American College of Cardiology (1 paper)The Journal of Clinical Endocrinology & Metabolism (1 paper)
- Partner nations
- United StatesUnited KingdomAustralia
In The Last Decade
Eduardo Dunayevich
46 papers receiving 3.9k citations
Hit Papers
Peers
Comparison fields: 5 of 99
- Pharmacology 2.3k
- Endocrinology, Diabetes and Metabolism 1.2k
- Psychiatry and Mental health 1.1k
- Biological Psychiatry 129
- Endocrine and Autonomic Systems 345
Countries citing papers authored by Eduardo Dunayevich
This map shows the geographic impact of Eduardo Dunayevich's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Eduardo Dunayevich with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Eduardo Dunayevich more than expected).
Fields of papers citing papers by Eduardo Dunayevich
This network shows the impact of papers produced by Eduardo Dunayevich. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Eduardo Dunayevich. The network helps show where Eduardo Dunayevich may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Eduardo Dunayevich, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2024 | 15 | |
| 2 | 2023 | 34 | |
| 3 | Cannabidiol (CBD; 10 And 20 MG/KG/Day) Significantly Reduces Convulsive Seizure Frequency In Children And Adolescents With Dravet Syndrome: Results Of A Dose-Ranging, Multi-Center, Randomised, Double-Blind, Placebo-Controlled Trial (GWPCARE2) | 2019 | 1 |
| 4 | 2019 | 19 | |
| 5 | 2017 | 37 | |
| 6 | 2016 | 30 | |
| 7 | 2015 | 132 | |
| 8 | 2015 | 98 | |
| 9 | 2014 | 5 | |
| 10 | 2013 | 33 | |
| 11 | 2013 | 65 | |
| 12 | 2010 | 39 | |
| 13 | 2008 | 2 | |
| 14 | 2007 | 35 | |
| 15 | 2007 | 99 | |
| 16 | 2007 | 147 | |
| 17 | 2005 | 23 | |
| 18 | 2004 | 70 | |
| 19 | 2001 | 15 | |
| 20 | 2000 | 135 |
About Eduardo Dunayevich
Eduardo Dunayevich is a scholar working on Psychiatry and Mental health, Biological Psychiatry and Pharmacology, having authored 47 papers that have together received 4.1k indexed citations. Recurring topics across this work include Schizophrenia research and treatment (15 papers), Pharmacology and Obesity Treatment (9 papers), Cannabis and Cannabinoid Research (9 papers), Epilepsy research and treatment (9 papers), Eating Disorders and Behaviors (7 papers), Bipolar Disorder and Treatment (6 papers), Health Systems, Economic Evaluations, Quality of Life (6 papers) and Treatment of Major Depression (6 papers). The work is most often cited by research in Pharmacology (2.3k citations), Endocrinology, Diabetes and Metabolism (1.2k citations) and Psychiatry and Mental health (1.1k citations). Eduardo Dunayevich has collaborated with scholars based in United States, United Kingdom and Australia. Frequent co-authors include J. Erickson, Frank L. Greenway, Ken Fujioka, Dennis Dong Hwan Kim, Maria Guttadauria, Paul E. Keck, Raymond A Plodkowski, Sunder Mudaliar, Gary D. Tollefson and Ronald Landbloom. Their work appears in journals such as The Lancet, Journal of the American College of Cardiology and The Journal of Clinical Endocrinology & Metabolism.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.